Status | Study |
Completed |
Study Name: The Expression of Serum Angiogenesis Marker in Patients Presenting With Hemoptysis Condition: Inflammatory Lung Diseases Hemoptysis Date: 2010-07-16 |
Completed |
Study Name: Urokinase Like Plasminogen Activator Levels in Patients Undergoing Bronchoscopy Condition: Hemoptysis Date: 2009-06-24 |
Completed |
Study Name: Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab Condition: Adenosquamous Cell Lung Cancer Drug/Agent Toxicity by Tissue/Organ Date: 2006-10-12 Interventions: Biological: bevacizumab Given |